On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy,...

One week after Canadian officials approved GlaxoSmithKline’s shingles vaccine, Shingrix, the US Food and Drug Administration (FDA) gave the vaccine it’s approval. The FDA on Friday approved...

GlaxoSmithKline (GSK) announced the publication of detailed results from a randomized phase III study (ZOE-70) of its investigational shingles vaccine, showing 90% efficacy in adults aged 70 years and...